Societal preferences for rheumatoid arthritis treatments: evidence from a discrete choice experiment

Predictors for the 5-year risk of serious infections in patients with rheumatoid arthritis treated with anti-tumour necrosis factor therapy: a cohort study in the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry

(2013) S. A. A. van Dartel et al.   RHEUMATOLOGY

Patient Preferences for Biologic Agents in Rheumatoid Arthritis: A Discrete-Choice Experiment

(2013) Federico Augustovski et al.   VALUE IN HEALTH

Patients' Willingness to Trade Off Between the Duration and Frequency of Rheumatoid Arthritis Treatments

(2013) Christine Poulos et al.   ARTHRITIS CARE & RESEARCH

Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis

(2012) Ronald F. van Vollenhoven et al.   NEW ENGLAND JOURNAL OF MEDICINE

Systematic Review and Meta-Analysis of the Efficacy and Safety of Existing TNF Blocking Agents in Treatment of Rheumatoid Arthritis

(2012) Kalle J. Aaltonen et al.   PLoS One

Using qualitative methods for attribute development for discrete choice experiments: issues and recommendations

(2011) Joanna Coast et al.   HEALTH ECONOMICS

GRADE guidelines: 3. Rating the quality of evidence

(2011) Howard Balshem et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Using a discrete choice experiment to estimate health state utility values

(2011) Nick Bansback et al.   JOURNAL OF HEALTH ECONOMICS

The risk of serious infections in patients receiving anakinra for rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register

(2011) J. B. Galloway et al.   RHEUMATOLOGY

Discrete choice experiments in health economics: a review of the literature

(2010) Esther W. de Bekker-Grob et al.   HEALTH ECONOMICS

Preference-based condition-specific measures of health: what happens to cross programme comparability?

(2010) John Brazier et al.   HEALTH ECONOMICS

Patient preferences and satisfaction in the treatment of rheumatoid arthritis with biologic therapy

(2010) Jennifer Barton   Patient Preference and Adherence

A discrete choice experiment evaluation of patients' preferences for different risk, benefit, and delivery attributes of insulin therapy for diabetes management

(2010) C Guimaraes et al.   Patient Preference and Adherence

The Role of Patient Preferences in Cost-Effectiveness Analysis

(2009) John E. Brazier et al.   PHARMACOECONOMICS

Why Do Patients with Inflammatory Arthritis Often Score States “Worse than Death” on the EQ-5D? An Investigation of the EQ-5D Classification System

(2009) Mark J. Harrison et al.   VALUE IN HEALTH

Health state utility values: A description of their development and application for rheumatic diseases

(2008) Nick Bansback et al.   ARTHRITIS AND RHEUMATISM